David Wolk, MD
University of Pennsylvania
- 4 editions
- 6 talks
- 6 recordings
2022
- Symposium, Day 1 · Keynote Symptomatic, Cognitive and Biomarker Heterogeneity in the Preclinical and Prodromal Stages of Alzheimer’s Disease
2019
- Symposium · Co-Chair Multimodal Imaging in the Diagnosis of Incipient Neurodegenerative Diseases
- Symposium Multimodal Imaging in the Diagnosis of Incipient Neurodegenerative Disease
2015
- Symposium What is the Etiology of Amyloid Negative Mild Cognitive Impairment?
2014
- Symposium Clinical Implications of Concordant and Discordant Beta-Amyloid and Neurodegenerative Abnormalities in Mild Cognitive Impairment
- Workshop Case 1: Clinical Implications of Discordant Biomarkers
- Public Forum Incorporating Biomarkers of Amyloid and Neurogeneration in Clinical Evaluation of Mild Cognitive Impairment
- Public Forum · Panelist The Role of Amyloid Imaging in the Diagnosis of Mild Cognitive Impairment: Current Research and Clinical Utility
Degrees and affiliation are current where known; the program pages show affiliations as they were each year.